Francesca Mangialasche

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age
    Francesca Mangialasche
    Aging Research Center, Karolinska Institutet, Stockholm, Sweden
    J Alzheimers Dis 20:1029-37. 2010
  2. ncbi Dementia prevention: current epidemiological evidence and future perspective
    Francesca Mangialasche
    Aging Research Center, Department of Neurobiology, Care Sciences and Society NVS, Karolinska Institutet KI Stockholm University, Gävlegatan 16 9th floor SE 113 30, Stockholm, Sweden
    Alzheimers Res Ther 4:6. 2012
  3. ncbi Alzheimer's disease: clinical trials and drug development
    Francesca Mangialasche
    Aging Research Center, Karolinska Institutet, Stockholm, Sweden
    Lancet Neurol 9:702-16. 2010
  4. ncbi Rethinking Alzheimer's disease therapy: are mitochondria the key?
    Maria Ankarcrona
    KI Alzheimer s Disease Research Center, Karolinska Institutet, Department of Neurobiology, Care Sciences and Society NVS, Huddinge, Sweden
    J Alzheimers Dis 20:S579-90. 2010
  5. ncbi Brain aging: lessons from community studies
    Laura Fratiglioni
    Aging Research Center, Karolinska Institutet, Stockholm, Sweden
    Nutr Rev 68:S119-27. 2010
  6. ncbi Aging with multimorbidity: a systematic review of the literature
    Alessandra Marengoni
    Aging Research Center, NVS Department, Karolinska Institutet and Stockholm University, Sweden
    Ageing Res Rev 10:430-9. 2011

Detail Information

Publications6

  1. ncbi High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age
    Francesca Mangialasche
    Aging Research Center, Karolinska Institutet, Stockholm, Sweden
    J Alzheimers Dis 20:1029-37. 2010
    ..The neuroprotective effect of vitamin E seems to be related to the combination of different forms, rather than to alpha-tocopherol alone, whose efficacy in interventions against AD is currently debated...
  2. ncbi Dementia prevention: current epidemiological evidence and future perspective
    Francesca Mangialasche
    Aging Research Center, Department of Neurobiology, Care Sciences and Society NVS, Karolinska Institutet KI Stockholm University, Gävlegatan 16 9th floor SE 113 30, Stockholm, Sweden
    Alzheimers Res Ther 4:6. 2012
    ..Taking a step in this direction, researchers involved in these European RCTs recently started the European Dementia Prevention Initiative, an international collaboration aiming to improve strategies for preventing dementia...
  3. ncbi Alzheimer's disease: clinical trials and drug development
    Francesca Mangialasche
    Aging Research Center, Karolinska Institutet, Stockholm, Sweden
    Lancet Neurol 9:702-16. 2010
    ....
  4. ncbi Rethinking Alzheimer's disease therapy: are mitochondria the key?
    Maria Ankarcrona
    KI Alzheimer s Disease Research Center, Karolinska Institutet, Department of Neurobiology, Care Sciences and Society NVS, Huddinge, Sweden
    J Alzheimers Dis 20:S579-90. 2010
    ..In this review, we will discuss current available medications for AD, drugs under clinical testing, and mitochondria as a novel drug target...
  5. ncbi Brain aging: lessons from community studies
    Laura Fratiglioni
    Aging Research Center, Karolinska Institutet, Stockholm, Sweden
    Nutr Rev 68:S119-27. 2010
    ..Presented here is an overview of the main findings of epidemiological studies on nutritional factors and nutrition-related pathological conditions, as related to dementia and Alzheimer's disease...
  6. ncbi Aging with multimorbidity: a systematic review of the literature
    Alessandra Marengoni
    Aging Research Center, NVS Department, Karolinska Institutet and Stockholm University, Sweden
    Ageing Res Rev 10:430-9. 2011
    ..New insights in this field can lead to the identification of preventive strategies and better treatment of multimorbid patients...